JPMORGAN CHASE & CO - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is and the CUSIP is 33830X904. A total of 5 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$437,000
+104.2%
11,600
-66.9%
0.00%
Q2 2020$214,000
+189.2%
35,000
+7.7%
0.00%
Q1 2020$74,000
-86.2%
32,500
-18.8%
0.00%
Q1 2019$536,000
-37.6%
40,000
-20.0%
0.00%
Q1 2018$859,000
-21.6%
50,0000.0%0.00%
Q4 2017$1,096,000
-47.2%
50,0000.0%0.00%
-100.0%
Q4 2015$2,075,00050,0000.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 14,900$253,0000.00%
SIMPLEX TRADING, LLC 93$158,0000.00%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders